Salus IRB provides initial review of minimal risk research in accordance with 21 CFR 56.110 and 45 CFR 46.110. The research must meet the 21 CFR 56.111 and 45 CFR 46.111 criteria for IRB approval. The review may be carried out by the IRB chairperson or by one or more experienced reviewers designated by the IRB chairperson. To determine if your research is minimal risk, refer to Salus Form 100.C Supplemental for Expedited Review of Minimal Risk Research.
For more information, contact Client Services.